Experts: FDA, CMS Need Resources, Culture Shift To Collab On RWE

Health care policy experts say FDA and CMS need new staff, training and resources from Congress in order to collaborate on real-world evidence that could be used simultaneously for regulatory evaluation and new payment models. They also say a broad culture shift is needed in how the agencies think about and use medical product data -- a shift they say could take years to fully achieve even though FDA and CMS leaders appear open to working together on RWE. The...